Brian J. Lynch - SVP and General Counsel at Madrigal Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP and General Counsel
Stock Symbol
MDGL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Brian J. Lynch - trading volume in the past year for Madrigal Pharmaceuticals, Inc.

Holdings reported by Brian J. Lynch for Madrigal Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 17.7K $4.32M $243.92 Jan 23, 2024 Direct
Market Stock Unit 3.64K $888K $243.92 Jan 23, 2024 Direct Common Stock
Common Stock 530 $129K $243.92 Jan 23, 2024 In IRA
Stock Option (Right to Buy) 5.48K Jan 23, 2024 Direct Common Stock

Transactions reported by Brian J. Lynch for Madrigal Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.